1988
DOI: 10.1016/0006-2952(88)90762-9
|View full text |Cite
|
Sign up to set email alerts
|

The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
163
0
8

Year Published

1994
1994
2005
2005

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 365 publications
(178 citation statements)
references
References 30 publications
1
163
0
8
Order By: Relevance
“…interessante de medicamento que ainda é vendido como mistura racêmica. Relatos tem comprovado que a forma S do ibuprofeno é 160 vezes mais ativa que a forma R na síntese de prostaglandina in vitro 11,12 . Um grande investimento em pesquisas tem sido feito para desenvolver diferentes processos para obtenção da forma enantiomérica ativa deste fármaco.…”
Section: Introductionunclassified
“…interessante de medicamento que ainda é vendido como mistura racêmica. Relatos tem comprovado que a forma S do ibuprofeno é 160 vezes mais ativa que a forma R na síntese de prostaglandina in vitro 11,12 . Um grande investimento em pesquisas tem sido feito para desenvolver diferentes processos para obtenção da forma enantiomérica ativa deste fármaco.…”
Section: Introductionunclassified
“…Such bi-directional chiral inversion has previously been reported for the model substrate 2-PPA but in that case, the rate was faster in the (R) to (S) direction, resulting in an overall increase of the (S)-enantiomer with time (Hutt et al 1993 ;Hanlon et al 1994). The chiral inversion of the (S) to the (R) enantiomer of ketoprofen has only recently been reported in mammalian systems (Jamali et al 1997), although there was precedent for the inversion of ibuprofen in man in this direction (Lee et al 1985 ;Caldwell et al 1988).…”
Section: Discussionmentioning
confidence: 91%
“…In this context, it may b e interesting to note that a similar preference for the (2R)-enantiomer was observed for the activation of 2-phenylpropionic acids such as 2-(4-isobutylphenyl)-propionic acid (Ibuprofen) (Knights et al, 1988;Knihinicki et al, 1989). Together with a racemase acting on the CoA thioester (Shieh and Chen, 1993) [possibly the amethylacyl-CoA racemase (Schmitz e t al., 1994)] and acyl-CoA hydrolases, this results in an ATP-driven inversion of the (2R)-enantiomer in vivo (Lee e t al., 1984;Caldwell et al, 1988;Chen et al, 1991). A detailed kinetic analysis of the activation of branched-chain fatty acids is under way in our laboratory.…”
Section: Discussionmentioning
confidence: 99%